CFDB - Cystic Fibrosis DataBase

Welcome in CFDB (Cystic Fibrosis DataBase)!

This is a web-based, free access tool for health care professionals, researchers and students to evaluate in real time what are the current evidences about clinical efficacy of interventions in CF.

You'll find more than 2,000 studies divided in 8 sections, including Cochrane reviews, Cochrane protocols, DARE, HTA and Economic reviews, published RCT, published non-RCT, congress abstracts and ongoing trials.

Objective of CFDB (Cystic Fibrosis DataBase)

CFDB is a database and was ideated to classify clinical studies to get answers to specific questions:

  • which interventions are effective, in which groups of CF patients and for which outcomes?
  • to what extent do the results of the literature allow to make decisions for specific clinical issues? What issues need to be studied further?

This tool may help clinicians, researchers, students to have a faster updated view of clinical research in CF by using queries on the main topics in CF care. It could also be helpful to anyone going to design new studies, as it provides a concise description of what is currently known and what issues, on the contrast, need additional research.

Latest articles

Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis

Cochrane Database of Systematic Reviews - Cochrane Review

Details
  • 2018
  • Jat Kana R

Inhaled anti-pseudomonal antibiotics for long-term therapy in cystic fibrosis

Cochrane Database of Systematic Reviews - Cochrane Review

Details
  • 2018
  • Ryan Gerard

Eradication of early P. aeruginosa infection in children <7years of age with cystic fibrosis: The early study.

primary studies published RCT

Details
  • 2018
  • Ratjen F

Effects of an Antioxidant-enriched Multivitamin in Cystic Fibrosis: Randomized, Controlled, Multicenter Trial.

primary studies published RCT

Details
  • 2018
  • Sagel SD

Repaglinide versus insulin for newly diagnosed diabetes in patients with cystic fibrosis: a multicentre, open-label, randomised trial.

primary studies published RCT

Details
  • 2017
  • Ballmann M

Initiating transitional care for adolescents with cystic fibrosis at the age of 12 is both feasible and promising.

primary studies published, non RCT

Details
  • 2018
  • Skov M

Trial to Evaluate Efficacy and Safety of Lenabasum in Cystic Fibrosis - Phase 2 - Recruiting

ongoing trials trial from www.clinicaltrials.gov

Details
  • 2017
  • Corbus Pharmaceuticals Inc.|Cystic Fibrosis Foundation Therapeutics